ClinicalThought

Share

Program Content

Activities

  • Prognostic Testing in CLL
    Prognostic Marker Testing in Treatment-Naive Patients With CLL—Still Important
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 22, 2020

    Expires: September 21, 2021

  • MRD Evaluation in CLL
    Considering the Role of MRD Evaluation for Patients With CLL
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 29, 2020

    Expires: September 28, 2021

  • Noncovalent BTKi
    Overcoming BTK Resistance in CLL With Noncovalent BTK Inhibitors—Where We Are
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 25, 2020

    Expires: September 24, 2021

Faculty

cover img faculity

Danielle M. Brander, MD

Medical Instructor
Division of Hematologic Malignancies & Cellular Therapy
Department of Medicine
Duke University
Attending Physician, Hematologic Malignancies
Duke University Health System
Durham, North Carolina

cover img faculity

Jeffrey P. DONOTUSESharman, MD

Medical Oncologist
Willamette Valley Cancer Institute and Research Center
Springfield, Oregon

cover img faculity

Jeff DONOTUSESharman, MD

Medical Director of Hematology Research
Willamette Valley Cancer Institute
US Oncology
Eugene, Oregon

Provided by

ProCE Banner

Supporters

AstraZeneca